Table of Contents
Research & Development
| Takeda Signs US$400 M+ Gene Therapy Pact with Evozyne | Abstract html pdf |
| Lucy Haggerty |
Mergers & Acquisitions
| Pfizer Bolsters RSV Pipeline with US$525 M ReViral Acquisition | Abstract html pdf |
| Lucy Haggerty |
| GlaxoSmithKline Gets Momelotinib with US$1.9 B Sierra Oncology Buyout | Abstract html pdf |
| Sasha Yachu |
| Regeneron Bolsters I-O Portfolio with US$250 M Checkmate Acquisition | Abstract pdf html |
| Lucy Haggerty |
| Caladrius and Cend Merge to Become Lisata Therapeutics | Abstract pdf html |
| Lucy Haggerty |
This work is licensed under a Creative Commons Attribution 3.0 License.